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Research Articles

Method Development and Validation for the Estimation of
Ramipril and Atorvastatin in Pharmaceutical Formulation by
RP-HPLC
Mousumi Kar*, Sujit Pillai, Gaurav Sharma, Nitin Deshmukh, Kunwar Nagendra Krishna Singh
Email: mousumi.cop@gmail.com

Abstract
Atorvastatin and Ramipril were simultaneously estimated in pharmaceutical dosage forms by developing fast and
precise RP-HPLC method. Chromatographic separations on C18 column (4.6mm×250mm, 5µm) were achieved
using mixture of 0.1% OPA buffer (pH-3.0): Acetonitrile: Methanol, (45:50:05 v/v). pH adjustment of aqueous
phase was done by using 0.5% Triethylamine. The peak response was monitored at 227 nm after injecting
the sample into HPLC system at a flow rate of 1.0 ml/min. The calibration curve was linear over the range
of Ramipril 10-30μg / ml and Atorvastatin 20-60μg / ml. Atorvastatin’s average RT was 9.2826±0.0107 and
Ramipril was 4.548±0.0366. Atorvastatin’s percentage recovery value is 99.47% and Ramipril’s 98.50% which
confirms the excipients do not interfere in the formulation. Thus, the suggested HPLC technique can therefore
be used for the simultaneous determination of these two drugs in pharmaceutical dosage forms due to speed,
simplicity and high accuracy.
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Introduction
Atorvastatin is chemically referred to as [R(R*, R*)]-2-(4-fluoro- phenyl)- ß-δ- dihydroxy5-(1-methylethyl) -3- phenyl 4-[(phenylamino)
carbonyl]-1H- pyrrole-1- hepatonoic acid6. It is a
competitive inhibitor of HMG-CoA reductase, a lipid
lowering agent and used in hyper-cholestrolemia.
Ramipril is chemically referred to as (2s,3as,
6as)- 1- [(s)-2- [(s)-1-(ethoxycarbonyl)-3-phenyl
propyl] amino propanoyl] octahydrocyclopenta[6]
pyrrole-2- carboxylic acid. It is an angiotensin
converting enzyme drug and used in ranovascular
hypertension7. The present work describes the
development and validation of the RP-HPLC method
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that can quantify the drugs from the combined
forms of dosage simultaneously. For an individual
determination of Atorvastatin and Ramipril, few
chromatographic methods have been defined. The
aim of the present work was to develop and validate
an accurate technique for Atorvastatin and Ramipril
to be determined simultaneously. The method was
validated in accordance with ICH guidelines8.
Methodology
Instrumentation: YoungLin ACME900 HPLC
system with C-18 column (4.6 mm ×250mm, 5μm)
was used for the present study. Detection of the
eluted components was achieved using UV Detector
and digital pH meter was used to check the solution’s
pH.
Reagents and Chemicals
Torrent
Pharmaceutical
Pvt.
Ltd.
Baddi
provided pure samples of Atorvastatin and Ramipril.
The commercial sample of RAMIPTOR capsules (A to
Z Life Sciences,) containing 10mg Atorvastatin and 5mg
Ramipril were purchased from local pharmacy. Water,
methanol, acetonitrile (HPLC grade), Orhtophosphoric
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acid (85-88%) and Triethylamine were obtained from
Loba Chemie Pvt. Ltd. Mumbai.
Preparation of stock solutions
Stock solution was prepared by dissolving 100 mg of
each drug into 100 ml volumetric flasks comprising
100 ml of methanol individually and 10-60 mcg/
ml of working concentration of both drugs were
prepared.
Chromatographic conditions
In the present study, the 1% OPA buffer (pH-3.0):
Acetonitrile: Methanol, (45:50:05 v/v) are used as
mobile phase. pH adjustment of aqueous phase was
done by using 0.5% Triethylamine and then using
0.2 μ membrane filter, solution was filtered. Finally
all the solutions were degassed prior to use. The
column temperature was kept at ±250 C. Following
injection of the sample into the HPLC system at a
flow rate of 1.0 ml / min, the peak response was
monitored at 227 nm.
Recommended standard graph method
Following a systematic and comprehensive research
on various parameters concerned, the pure sample and
dosage forms of Atorvastatin and Ramipril used the
following operation and conditions for simultaneous
estimation. Before the drug solution was injected,
using mobile phase the column was saturated for
atleast 45 mins. Atorvastatin (10 mg) and Ramipril
(5mg) were accurately weighed and transferred
to volumetric flask of 100 ml and dissolved in
methanol. The quantity of Atorvastatin 100 mcg/
ml and Ramipril 50mcg/ml was produced upto the
mark with methanol. From this different dilution
of Ramipril 10-30 mcg/ml and Atorvastatin 20-60
mcg/ml with 20 mcg/ml using caffeine as internal
standard were made and AUC was determined. The
calibration curve was then plotted by ratio of AUC
of drug by internal standard vs concentration.
Assay of Atorvastatin and Ramipril in
formulations
The contents of the twenty Ramiptor capsules were
weighed accurately and the average weight was
calculated. The equivalent of 10 mg Atorvastatin
and 5 mg Ramipril were taken and dissolved in
methanol in a volumetric flask of 100 ml. The final
concentration of Atorvastatin 100 mcg/ml and
48

Ramipril 50 mcg/ml was produced with methanol.
From this different dilution of Ramipril (10-30
mcg/ml) and Atorvastatin (20-60 mcg/ml) were
made and AUC was determined using caffeine as
internal standard. Finally, sonicated the solution for
3 min, filtered through Whatmann filter paper and
lastly diluted the filtrate to final concentration with
solvent.

Figure 1: Typical Chromatogram

Validation of developed HPLC Method
Linearity: For Atorvastatin in the concentration
range of 20-60 mcg/ml and for Ramipril 10-30
mcg/ml, the standard curve was achieved. The
linearity of this technique was assessed utilizing
the least square technique using linear regression
analysis.
Precision
Precision of the method was determined in terms
of repeatability, inter-day and intra-day precision.
For each of the middle concentrations, six injections
were given from the linearity range and then the
proportion of RSD was calculated. The variation in
the peak region of Atorvastatin and Ramipril drug
dilution was calculated in terms of coefficient of
variation.
Accuracy: The precision of the HPLC technique
was evaluated with the addition of known quantities
of drugs i.e. 80 percent and 120 percent of the
middle concentration from the linearity plot was
selected and spiked in pre-analyzed drug solution.
The samples were then analyzed by the proposed
HPLC technique in triplicates and % Relative
Standard Deviation and recovery was determined.
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Limit of detection (LOD) and limit of
quantification (LOQ): LOD is the drug’s minimum
concentration that is detectable. The measured
reference and test replicates of a sample containing
a low drug concentration are used to determine the
LOD. LOQ is the lowest concentration at which
the analyte cannot be continually identified but
quantified as well. The LOQ may be equal to the
LOD or at concentration much greater.
Where, σ = SD of lowest concentration sample; m
= Slope
Results and Discussion
The method developed for both drugs was evaluated
for accuracy, linearity and accuracy and percentage
of RSD was calculated. The drug recovery was
found to be 98.5 percent and 99.47 percent with less
than 2 percent RSD value, respectively. Ramipril
LOD and LOQ values were 0.082 μg and 0.25 μg,
Atorvastatin 1.5 μg and 1.9 μg, respectively. It was
found that the linearity of the method is extremely
reproducible with R2 value of 0.999. Good linearity
was achieved within the concentration range of 2060 μg / ml for Atorvastatin and 10-30 μg / ml for
Ramipril respectively. Figure 1 shows the typical
chromatogram. Atorvastatin and Ramipril retention
time was found to be 3.10 and 9.27 min respectively
with both peaks being well resolved. The first peak
at 3.10 was of Atorvastatin while the second peak at
9.27 was of the Ramipril. The additional peak aprt
from these two peaks was observed consistently
when the process was repeated and hence it was
concluded to be of the mobile phase components
or any other ingredient. Number of Theoretical
plates was found to be 4376 and 577, respectively for
Atorvastatin and Ramipril. Tailing factor was found
to be 1.215 and 1.224 for Atorvastatin and Ramipril,
respectively. With respect to precision, %RSD was
found to be <2% for both the drugs.
Conclusion
The RP-HPLC method was developed to estimate
Ramipril and Atorvastatin drugs and this method

can be used in the pharmaceutical formulations to
estimate these drugs simultaneously.
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